Genetic and ultrasound assessment in recurrent fetal malformations: a case report on TUBA1A gene variation
Yu Jiang , Lili Wu , Liya Du , Zhenyu Luo , Hao Zhao , Mei Lu , Yanhong Zhang
Journal of Translational Genetics and Genomics ›› 2026, Vol. 10 ›› Issue (1) : 33 -41.
To elucidate the etiology of recurrent fetal brain developmental malformations accompanied by other structural ultrasound anomalies in a Chinese non-consanguineous couple, we performed a comprehensive evaluation of prenatal ultrasound phenotypes across their two consecutive pregnancies. Copy number variation sequencing and exome sequencing were applied to the amniotic fluid sample obtained from the affected pregnancy. One copy number variation and four candidate missense variants in three genes identified in the initial analysis were reassessed and reclassified according to current clinical and genetic evidence. Our results demonstrated that a maternal mosaic c.7G>A(p.Glu3Lys) variant in the tubulin alpha 1a (TUBA1A) gene was the underlying cause of the couple’s recurrent adverse pregnancy outcomes. These findings enrich the database of pathogenic TUBA1A variants, expand the spectrum of associated prenatal ultrasound phenotypes, and provide valuable insights into the underlying pathogenic mechanisms.
TUBA1A / tubulinopathy / prenatal phenotype / parental mosaicism / case report
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
Brar BK, Thompson MG, Vora NL, et al.; Fetal Sequencing Consortium. Prenatal phenotyping of fetal tubulinopathies: a multicenter retrospective case series Prenat Diagn. 2022 42 1686 93 PMC9805891 |
| [6] |
|
| [7] |
Richards S, Aziz N, Bale S, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genet Med. 2015 17 405 24 PMC4544753 |
| [8] |
Wilcox EH, Webb RF, Tshering KC, et al.; ClinGen RASopathy Expert Panel. Updated ACMG/AMP specifications for variant interpretation and gene curations from the ClinGen RASopathy expert panels Genet Med Open. 2025 3 103430 PMC12151217 |
| [9] |
Tavtigian SV, Greenblatt MS, Harrison SM, et al.; ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI). Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework Genet Med. 2018 20 1054 60 PMC6336098 |
| [10] |
|
| [11] |
Abou Tayoun AN, Pesaran T, DiStefano MT, et al.; ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI). Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion Hum Mutat. 2018 39 1517 24 PMC6185798 |
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
Monaghan KG, Leach NT, Pekarek D, Prasad P, Rose NC.; ACMG Professional Practice and Guidelines Committee. The use of fetal exome sequencing in prenatal diagnosis: a points to consider document of the American College of Medical Genetics and Genomics (ACMG) Genet Med. 2020 22 675 80 |
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
ClinGen Sequence Variant Interpretation Recommendation for de novo Criteria (PS2/PM6) - Version 1.1. Available from: https://www.clinicalgenome.org/site/assets/files/3461/svi_proposal_for_de_novo_criteria_v1_1.pdf. [Last accessed on 12 Mar 2026] |
| [33] |
ClinGen Sequence Variant Interpretation Recommendation for PM2 - Version 1.0. Available from: https://www.clinicalgenome.org/site/assets/files/5182/pm2_-_svi_recommendation_-_approved_sept2020.pdf. [Last accessed on 12 Mar 2026] |
/
| 〈 |
|
〉 |